Intra-cellular therapies to present at the 43rd annual j.p. morgan healthcare conference

Bedminster, n.j., jan. 06, 2025 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that sharon mates, ph.d., chief executive officer and chairman, is scheduled to present at the 43rd annual j.p. morgan healthcare conference on monday, january 13, 2025 at 11:15 a.m. pt in san francisco, ca.
ITCI Ratings Summary
ITCI Quant Ranking